To produce transgenic mice which express T cell receptors specific for (IRBP).
产生表达特异T细胞受体(IRBP)的转基因小鼠。
基本信息
- 批准号:7535963
- 负责人:
- 金额:$ 25.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:5-(6)-carboxyfluorescein diacetate succinimidyl esterAdoptive TransferAntigensApplications GrantsAreaAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityBackcrossingsBiomedical ResearchBreedingCell physiologyCellsCloningCommunitiesDevelopmentDiabetes MellitusDiseaseDisease modelEffector CellEpitopesExperimental Autoimmune EncephalomyelitisExperimental ModelsExploratory/Developmental GrantEyeFailureFluorescent DyesFosteringGenesGoalsImmuneImmune ToleranceImmune responseImmunizationIn VitroKnockout MiceLabelLeadLengthMediatingMethodsMicroinjectionsMicrotusModelingMononuclearMultiple SclerosisMusNumbersPancreasPeripheralPhotoreceptorsPolymerase Chain ReactionPopulationPosterior UveitisPre-Clinical ModelProcessProductionPropertyPublic HealthRIII MouseReceptor GeneResearchResearch PersonnelResearch Project GrantsRetinaRiskRoleSiteSourceSpecificitySystemT-Cell ReceptorT-Cell Receptor GenesT-LymphocyteTestingThymic epithelial cellThymus GlandTissuesTransfectionTransgenesTransgenic MiceTransgenic OrganismsUveitisVisionalpha-beta T-Cell Receptorautoimmune uveitisbeta Chain Antigen T Cell Receptordesignin vivointerstitial retinol-binding proteinintravital microscopymodel developmentmouse interstitial retinol-binding proteinmouse modelnovelreceptorreceptor expressionresearch studysuccesszygote
项目摘要
DESCRIPTION (provided by applicant): Autoimmune posterior uveitis is a T cell mediated autoimmune disease characterized by mononuclear infiltrate into the retina and irreversible photoreceptor destruction. While the cause is unknown, experimental autoimmune uveitis (EAU) can be induced in mice through immunization with interphotoreceptor retinoid binding protein (IRBP). Numerous studies in the EAU field as well as other autoimmune disease models suggest that the primary cause of autoimmune disease is a failure of immune tolerance mechanisms. T cell receptor (TCR) transgenic mice have provided, and continue to provide, a wealth of important information on mechanisms of tolerance induction as well as mechanisms of autoimmune tissue destruction, particularly in the multiple sclerosis and diabetes fields. In this exploratory/developmental research grant application, the applicant proposes to develop TCR transgenic mice with specificity for IRBP as a new model for EAU. The applicant has successfully cloned full length cDNAs encoding the alpha and beta chains of the TCR from three IRBP specific T cell clones, and is in the process of cloning the receptor genes from two other T cell clones. In the first aim, the applicant will generate two lines of transgenic mice from two different T cell clones. In the second aim, the applicant will perform the initial characterization of the lines in order to establish them as useful models for EAU. These mice will be made available to the uveitis research community and create valuable new models for uveitis research. Studies using these mice may lead to new therapies for the treatment of uveitis.
PUBLIC HEALTH RELEVANCE: This project will generate new transgenic mouse models for autoimmune uveitis, a severe sight threatening autoimmune disease. Similar mouse models have been produced for multiple sclerosis and diabetes and have been responsible for dramatic advances in those fields. These mice will be made available to the research community and thus foster new research into cures or treatment for autoimmune uveitis.
描述(由申请人提供):自身免疫性后葡萄膜炎是一种T细胞介导的自身免疫性疾病,其特征为单核细胞浸润至视网膜和不可逆的感光细胞破坏。虽然原因不明,但可通过光感受器间类维生素A结合蛋白(IRBP)免疫小鼠诱导实验性自身免疫性葡萄膜炎(EAU)。EAU领域以及其他自身免疫性疾病模型中的许多研究表明,自身免疫性疾病的主要原因是免疫耐受机制的失败。T细胞受体(TCR)转基因小鼠已经并将继续提供大量关于耐受诱导机制以及自身免疫组织破坏机制的重要信息,特别是在多发性硬化症和糖尿病领域。在这项探索性/开发性研究资助申请中,申请人提议开发对IRBP具有特异性的TCR转基因小鼠,作为EAU的新模型。申请人已成功地从三个IRBP特异性T细胞克隆中克隆了编码TCR α和β链的全长cDNA,并且正在从另外两个T细胞克隆中克隆受体基因。在第一个目标中,申请人将从两个不同的T细胞克隆产生两个转基因小鼠系。在第二个目标中,申请人将对品系进行初步表征,以将其确立为EAU的有用模型。这些小鼠将提供给葡萄膜炎研究社区,并为葡萄膜炎研究创造有价值的新模型。使用这些小鼠的研究可能会导致治疗葡萄膜炎的新疗法。
公共卫生相关性:该项目将产生新的转基因小鼠模型的自身免疫性葡萄膜炎,严重的视力威胁自身免疫性疾病。已经为多发性硬化症和糖尿病制作了类似的小鼠模型,并在这些领域取得了巨大进展。这些小鼠将提供给研究界,从而促进对自身免疫性葡萄膜炎的治愈或治疗的新研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerold G Woodward其他文献
Unfolded Von Willebrand Factor Interacts with Protein S and Limits Its Anticoagulant Activity
- DOI:
10.1182/blood-2022-162612 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Martha MS Sim;Hammodah Alfar;Melissa Hollifield;Dominic W. Chung;Xiaoyun Fu;Meenakshi Banerjee;Chi Peng;Xian Li;Alice Thornton;James Z Porterfield;Jamie Sturgill;Gail A Sievert;Marietta Barton-Baxter;Kenneth S Campbell;Jerold G Woodward;José A. López;Sidney W Whiteheart;Beth A Garvy;Jeremy P Wood - 通讯作者:
Jeremy P Wood
Jerold G Woodward的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jerold G Woodward', 18)}}的其他基金
Chylomicrons promote intestinal absorption and systemic dissemination of dietary
乳糜微粒促进肠道吸收和膳食的全身传播
- 批准号:
8053458 - 财政年份:2010
- 资助金额:
$ 25.64万 - 项目类别:
To produce transgenic mice which express T cell receptors specific for (IRBP).
产生表达特异T细胞受体(IRBP)的转基因小鼠。
- 批准号:
7675985 - 财政年份:2008
- 资助金额:
$ 25.64万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 25.64万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 25.64万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 25.64万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 25.64万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 25.64万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 25.64万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 25.64万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 25.64万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 25.64万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 25.64万 - 项目类别: